RFA for GIM Treatment

Status Completed

Clinical Trial Summary

Use radiofrequency ablation (RFA) for Gastric intestinal metaplasia (GIM) treatment.

Clinical Trial Description

Gastric intestinal metaplasia (GIM) is a pre-malignant lesion. Currently, there is no standard treatment for this condition, thus the patients with GIM need surveillance endoscopy every 1-3 years, regarding to the severity and extension of lesion. However, the protocol for GIM surveillance is uncertain and need high cost. Radiofrequency ablation (RFA) is used for Barrett's esophagus (BE; pre-malignant lesion of esophageal adenoCA) treatment as a standard treatment. The investigators hypothesized that RFA may effective in GIM treatment. The investigators will random GIM participants to have the RFA treatment only one site of the stomach (left or right). At the first session, the investigators will biopsy at suspected GIM lesions to confirm the diagnosis and severity of GIM. Two months later, The investigators will apply RFA to all GIM lesions at the assigned location and then every 2 months for 3 sessions or until no GIM lesion seen by endoscopy. The final endoscopy will be done at 1 year follow-up and biopsy will be performed to assess the efficacy of RFA compare to no treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04348266
Study type	Interventional
Source	King Chulalongkorn Memorial Hospital
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2020
Completion date	May 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05243134` - The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
Completed	`NCT02486874` - Clinical Evaluation of PoreSkin	Phase 1
Active, not recruiting	`NCT04592640` - Stem Cells for Uremic Calciphylaxis Patients	N/A
Recruiting	`NCT04599686` - Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer	N/A
Recruiting	`NCT03351842` - Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%	Phase 2
Completed	`NCT02782442` - Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)	N/A
Completed	`NCT03439930` - The Effect of Balance Training on Neuromuscular Control in Subjects With CAI	N/A
Not yet recruiting	`NCT05537155` - Buccal Acupuncture for Delirium Treatment in Older Patients Recovering From Orthopedic Surgery	N/A
Recruiting	`NCT02971982` - PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia	Phase 1/Phase 2
Completed	`NCT02820272` - Water for Reducing Pain in Negative Pressure Wound Therapy	Phase 2
Completed	`NCT00984958` - Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure	N/A
Completed	`NCT00575224` - Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9	Phase 4
Completed	`NCT00164528` - Intervening With Children/Adolescents With FAS/ARND	Phase 1/Phase 2
Completed	`NCT00164307` - Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships	Phase 1/Phase 2
Recruiting	`NCT04603586` - Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses	N/A
Recruiting	`NCT03375424` - Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany	N/A
Not yet recruiting	`NCT04062370` - Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion	Phase 4
Not yet recruiting	`NCT02931136` - Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging	Phase 4
Completed	`NCT04661228` - Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)
Recruiting	`NCT03365141` - Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo	N/A